Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05455619
Title Evexomostat Plus Alpelisib and Fulvestrant in Women With the PIK3CA Mutation With HR+/Her2- Breast Cancer (Amelia-1)
Acronym Amelia-1
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors SynDevRx, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Loma Linda University Cancer Center RECRUITING Loma Linda California 92354 United States Details
Cedars-Sinai Medical Center WITHDRAWN Los Angeles California 90048 United States Details
Hoag Memorial Hospital Presbyterian RECRUITING Newport California 92663 United States Details
Miami Cancer Institute at Baptist Health RECRUITING Miami Florida 33176 United States Details
University of Maryland Baltimore RECRUITING Baltimore Maryland 21201 United States Details
Toledo Clinic Cancer Center RECRUITING Toledo Ohio 43623 United States Details
Vanderbilt University Medical Center RECRUITING Nashville Tennessee 37232 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field